(Q44124129)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mara De Amici

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gino R Corazza

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

S Quaglini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

C Paglino

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

F Tagliani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

A Boncimino

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

R Moratti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

24 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

353-358

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17962206%20AND%20SRC:MED&resulttype=core&format=json

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Interleukin-6, CD45 and the src-kinases in myeloma cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Elevated serum interleukin-6 levels in patients with pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Rising incidence of hepatocellular carcinoma: the role of hepatitis B and C; the impact on transplantation and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Expression of the hepatocyte growth factor-like protein gene in human hepatocellular carcinoma and interleukin-6-induced increased expression in hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Effect of IL-6 overexpression on the metastatic potential of rat hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Alphafetoprotein: an obituary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Medroxyprogesterone Acetate Decreases Secretion of Interleukin-6 and Parathyroid Hormone-Related Protein in a New Anaplastic Thyroid Cancer Cell Line, KTC-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448

Managing cancer-related anorexia/cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDM448